# US 2003/0228316 A1 · Mitochondrial creatine kinase antibody

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228316 A1
- Document ID: US20030228316A1
- Status: Published application
- Kind: A1
- Application number: 10/424,740
- Filed: 2003-04-29
- Published: 2003-12-11
- Earliest claimed: 2002-04-30
- Assignees: International Reagents Corporation
- Inventors: Yasushi Shirahase; Tadahiro Kajita; Koji Kishi; Kazuaki Yamashita
- Web page: https://patentgrep.com/patent/US20030228316A1

## CPC

- C07K 16/40: against enzymes
- Y10S 435/975: Kit
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The object of the present invention is to provide a method for more accurately assaying the enzyme activities of mCK isozymes and a method for separately assaying the enzyme activities of CK isozymes by separately assaying the enzyme activities of ubiquitous mCK (umCK) and sarcomeric mCK (smCK). The above object is attained by an assay using an antibody that specifically recognizes umCK protein. In addition, other anti-mCK antibodies (e.g., anti-smCK antibody) and/or anti-human CK-M-inhibiting antibody can also be used. The above antibody is a polyclonal antibody or a monoclonal antibody. As a result of these antibodies, a monoclonal antibody (U1-1881) that is capable of specifically recognizing human umCK and is produced by a hybridoma having a deposition number of FERM BP-8342 is provided.

## Claims

### Claim 1

An anti-mCK antibody that inhibits an enzyme activity of ubiquitous mCK (umCK) among creatine kinase isozymes localized in mitochondria (mCK).

### Claim 2 (depends on 1)

The antibody according to claim 1, wherein the antibody inhibits the enzyme activity of umCK at 60% or more.

### Claim 3 (depends on 1)

The antibody according to claim 1, wherein the antibody is capable of inhibiting the enzyme activity of mCK down to such a level that an assay of CK isozymes other than mCK isozymes is not substantially affected.

### Claim 4 (depends on 1)

The antibody according to claim 1, wherein the antibody is a monoclonal antibody.

### Claim 5

A monoclonal antibody produced by a hybridoma having a deposition number FERM BP-8342.

### Claim 6

A hybridoma having a deposition number FERM BP-8342.

### Claim 7

A method for immunologically assaying mCK, comprising steps of providing a specimen; and treating the specimen with an antibody for inhibiting an enzyme activity of umCK.

### Claim 8 (depends on 7)

The method according to claim 7, comprising a step of treating the specimen with an anti-mCK antibody for inhibiting an enzyme activity of sarcomeric mCK (smCK) among mCK isozymes.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the step of treating the specimen with the antibody for inhibiting the enzyme activity of umCK and the step of treating the specimen with the antibody for inhibiting the enzyme activity of smCK are carried out in one step.

### Claim 10

A method for assaying CK isozymes, comprising steps of providing a specimen; and treating the specimen with an antibody for inhibiting an enzyme activity of umCK.

### Claim 11 (depends on 10)

The method according to claim 10, the treating step is performed by treating the specimen with the antibody for inhibiting the enzyme activity of umCK and an antibody for inhibiting an enzyme activity of smCK.

### Claim 12 (depends on 10)

The method according to claim 10, comprising a step of assaying an enzyme activity of CK in the specimen before the step of treating with the antibody, and a step of assaying a remaining enzyme activity after the step of treating with the antibody.

### Claim 13 (depends on 10)

The method according to claim 10, comprising a step of treating the specimen with an anti-CK-M subunit antibody.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the step of treating the specimen with the antibody for inhibiting the enzyme activity of umCK and the step of treating the specimen with the anti-CK-M subunit antibody are carried out in one step.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the step of treating the specimen with the antibody for inhibiting the enzyme activity of umCK and the step of treating the specimen with the anti-CK-M subunit antibody are carried out in two steps.

### Claim 16 (depends on 15)

The method according to claim 15, comprising steps of treating the specimen with the anti-CK-M subunit antibody; assaying a first remaining enzyme activity of the specimen; treating the specimen with the antibody for inhibiting the enzyme activity of umCK; and assaying a second remaining enzyme activity of the specimen.

### Claim 17

A method for testing CK isozymes, comprising steps of assaying CK isozymes including a step of treating the specimen with an antibody for inhibiting an enzyme activity of umCK; and relating a result of assay with disease.

### Claim 18

A reagent for assaying CK isozymes, comprising anti-mCK antibody for inhibiting an enzyme activity of umCK among mCK isozymes.

### Claim 19 (depends on 18)

The reagent according to claim 18, comprising an anti-CK-M subunit antibody.

### Claim 20 (depends on 19)

The reagent according to claim 19, comprising an anti-mCK antibody for inhibiting an enzyme activity of smCK among mCK isozymes.

### Claim 21

A reagent kit for assaying CK isozymes, comprising a reagent including anti-mCK antibody for inhibiting an enzyme activity of umCK among mCK isozymes.

### Claim 22 (depends on 21)

The reagent kit according to claim 21, comprising a reagent including an anti-CK-M subunit antibody.

### Claim 23 (depends on 21)

The reagent kit according to claim 21, wherein the reagent including an anti-mCK antibody for inhibiting an enzyme activity of smCK among mCK isozymes.
